Cargando…
NTRK Fusions in 1113 Solid Tumors in a Single Institution
SIMPLE SUMMARY: Recently, there has been increasing interest in identifying NTRK fusions in various tumors, as they are therapeutically targetable driver mutations. In tumor types with low-frequency NTRK fusions, recent recommendations on NTRK testing recommend pan-Trk immunohistochemistry (IHC) as...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222038/ https://www.ncbi.nlm.nih.gov/pubmed/35741260 http://dx.doi.org/10.3390/diagnostics12061450 |